1. Home
  2. FSUN vs PVLA Comparison

FSUN vs PVLA Comparison

Compare FSUN & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$38.93

Market Cap

966.0M

Sector

Finance

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$100.91

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
PVLA
Founded
1892
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
966.0M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FSUN
PVLA
Price
$38.93
$100.91
Analyst Decision
Buy
Strong Buy
Analyst Count
3
17
Target Price
$46.33
$145.24
AVG Volume (30 Days)
100.0K
253.4K
Earning Date
01-26-2026
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
3.52
N/A
EPS
3.16
N/A
Revenue
$384,497,000.00
N/A
Revenue This Year
$19.09
N/A
Revenue Next Year
$62.50
N/A
P/E Ratio
$12.27
N/A
Revenue Growth
10.48
N/A
52 Week Low
$29.95
$12.10
52 Week High
$45.32
$114.69

Technical Indicators

Market Signals
Indicator
FSUN
PVLA
Relative Strength Index (RSI) 57.37 52.07
Support Level $37.73 $90.85
Resistance Level $39.57 $106.27
Average True Range (ATR) 0.92 8.03
MACD -0.09 0.04
Stochastic Oscillator 56.99 75.89

Price Performance

Historical Comparison
FSUN
PVLA

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: